Electronic health records such as those maintained by hospitals and doctors’ offices don’t have a lot of value for healthcare researchers, which means new sources of health data are needed to improve quality in the U.S. healthcare system. And moving doctors away from paper patient records to EHRs won’t do a lot to reduce costs […]
The Austen BioInnovation Institute in Akron (ABIA) has created its first company: a firm that’s developing a noninvasive spinal fixation system for children with scoliosis. APTO Orthopaedics’ device is designed to eliminate the need for repetitive, painful and costly surgeries for children with scoliosis, who can require up to two surgeries per year to adjust […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The Austen BioInnovation Institute in Akron (ABIA) and Lubrizol have entered into a strategic partnership that involves research and development around medical applications of polymers and specialty chemicals. The partnership gives Wickliffe, Ohio-based Lubrizol access to the ABIA’s expertise in polymers, wound care and orthopedics. The ABIA, in return, will be able to leverage Lubrizol’s […]
The Austen BioInnovation Institute in Akron is collaborating with the U.S. Food and Drug Administration to share its expertise in the use of biomaterials and polymers in medical devices. The goal of the partnership is to help the FDA more effectively regulate the safety and performance of the materials when they’re used in the manufacture […]
The Austen BioInnovation Institute in Akron and the University of Akron are planning to launch in January a semester-long educational program aimed at women entrepreneurs. The program will provide participants with access to experts, coaching by successful entrepreneurs, contact with cutting-edge technology and support in forming companies and licensing ideas.
The Ohio Venture Association will focus on the world of biomedical technology when Frank Douglas, President and CEO of the Akron BioInnovation Institute, speaks at its upcoming lunch meeting.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
A nationally-renowned medical researcher will be featured in next month’s issue of GQ Magazine as a Rock Star of Science. Dr. Frank L. Douglas says the honor was unexpected, but “a thrill.” Douglas, 67, is founder and CEO of the Austen BioInnovation Institute of Akron. Since joining ABIA in September 2009, Douglas has led an […]
The University of Akron Research Foundation and the Austen BioInnovation Institute were awarded $1 million as winners of a federal competition designed to reward regional collaboration on innovation.
If the Austen BioInnovation Institute in Akron is to reach its goals of bringing 2,400 jobs and 60 biomedical companies to the city within 10 years, it's likely Brian Davis will be a big reason why.
This fall, BioOhio will hold its Annual Conference in three regions on three different dates. “Innovation Road Show” will visit northeast Ohio on September 28, central Ohio on October 28, and southwest Ohio on November 17. At all three sites, the emphasis will be on biomedical innovation — defining it, discussing it, debating it, and understanding how essential it is from R&D through commercialization to market. Ample networking time will be available for Ohio’s bioscience innovators to share ideas and initiate collaborations.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The Austen BioInnovation Institute in Akron has received a $2.6 million Ohio Third Frontier grant for biomedical sensor research and commercialization. The grant is from the revamped Wright Center for Sensor Systems Engineering at Cleveland State University.
The Austen BioInnovation Institute in Akron is among the big winners in a federal defense spending bill that cleared a critical U.S. House subcommittee on Tuesday. If ultimately approved by the full U.S. House and Senate and signed by the president, the measure will bring $5 million in federal money to the BioInnovation Institute. The […]
Updated 3:35 p.m. Akron and its Austen BioInnovation Institute in Akron are getting a big boost from Ohio. The city has been designated an Ohio Hub of Innovation and Opportunity in biomaterials, bringing with it a grant of $250,000 and support from the Ohio Department of Development to help it become a global leader in […]
The Austen BioInnovation Institute in Akron has landed three medical innovators to head its centers for medical device development, integrated health care education and community health improvement. The new vice presidents also will lead collaborative efforts across the institute’s operating partners on initiatives that focus on patient-centered innovation and commercialization in biomaterials and medicine. The […]
BioEnterprise Inc., the bioscience venture developer in Northeast Ohio, has formalized a partnership with Team NEO to woo new medical imaging, neurostimulation, cardiovascular device and orthopedic companies to the region. Both nonprofits work in Northeast Ohio and sometimes they bump against each other or duplicate efforts, said Annette Ballou, director of strategic marketing and communications for BioEnterprise. So the two organizations developed a […]